U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
Recommendation is based on pivotal data from the phase III POLARIX study
The product will be manufactured at Lupin’s facility in Goa, India
This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system
#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India
As part of this partnership, Huma and AstraZeneca will launch Software as a Medical Device (SaMD) companion apps targeted at several therapeutic areas and will partner to help accelerate the adoption of decentralized clinical trials
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Enables millions of Indians to monitor their vitals without the need of any additional device
Subscribe To Our Newsletter & Stay Updated
